Cholinergic Receptor, Nicotinic, alpha 3 (Neuronal) (CHRNA3) Peptid
CHRNA3
Reaktivität: Säugetier
Wirt: Synthetic
BP, WB, IHC
-
- Target Alle CHRNA3 Produkte
- CHRNA3 (Cholinergic Receptor, Nicotinic, alpha 3 (Neuronal) (CHRNA3))
- Protein-Typ
- Synthetic
- Spezies
- Säugetier
-
Quelle
- Synthetic
- Applikation
- Blocking Peptide (BP), Western Blotting (WB), Immunohistochemistry (IHC)
- Sequenz
- EHRLFERLFE DYNEIIRPVA NVSDPVIIHF EVSMSQLVKV DEVNQIMETN
- Produktmerkmale
-
A synthetic peptide for use as a blocking control in assays to test for specificity of CHRNA3 antibody,
Alternative Names: CHRNA3 control peptide, CHRNA3 antibody Blocking Peptide, Anti-CHRNA3 Blocking Peptide, Cholinergic Receptor Nicotinic Alpha 3 Blocking Peptide, MGC104879 Blocking Peptide
-
-
- Applikationshinweise
- Optimal conditions should be determined by the investigator
- Beschränkungen
- Nur für Forschungszwecke einsetzbar
-
- Format
- Lyophilized
- Rekonstitution
- Add 100 µL of distilled water for a final peptide concentration is 1 mg/mL.
- Buffer
- PBS
- Handhabung
- Avoid repeated freeze/thaw cycles.
- Lagerung
- -20 °C
- Informationen zur Lagerung
- Store at -20 °C long term.
-
- Target
- CHRNA3 (Cholinergic Receptor, Nicotinic, alpha 3 (Neuronal) (CHRNA3))
- Hintergrund
- The CHRNA3 subunit is expressed in the soma of the majority of pyramidal cells, with the most alpha 3 immunoreactivity observed in CA2-4 and entorhinal cortex and relatively less in CA1 and subicular pyramidal cell soma.
- Molekulargewicht
- 57 kDa
-
Sie sind hier:
